![Kyle W. H. Chan](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Kyle W. H. Chan
Direttore Tecnico/Scientifico/R&S presso BioTheryX, Inc.
Posizioni attive di Kyle W. H. Chan
Società | Posizione | Inizio | Fine |
---|---|---|---|
TheraVasc, Inc.
![]() TheraVasc, Inc. Pharmaceuticals: MajorHealth Technology TheraVasc, Inc. operates as a pharmaceutical company. It develops treatments for various chronic medical diseases and drugs for unserved vascular disease markets. The company was founded by Anthony Giordano, Christopher Kevil and James Douglas Boudreaux in 2008 and is headquartered in Cleveland, OH. | Direttore/Membro del Consiglio | - | - |
BioTheryX, Inc.
![]() BioTheryX, Inc. Pharmaceuticals: MajorHealth Technology BioTheryX, Inc. pengages in the development of clinical drugs. It focuses on the restoration of protein homeostasis, including protein degradation and modulation, and multi-kinase inhibition. The company was founded by David I. Stirling and Lawrence Zaslow in 2007 and is headquartered in Chappaqua, NY. | Direttore Tecnico/Scientifico/R&S | 01/07/2007 | - |
Storia della carriera di Kyle W. H. Chan
Precedenti posizioni note di Kyle W. H. Chan
Società | Posizione | Inizio | Fine |
---|---|---|---|
NOVADX VENTURES CORP. | Fondatore | 19/09/1983 | - |
CELGENE | Corporate Officer/Principal | - | - |
Formazione di Kyle W. H. Chan
Occidental College | Undergraduate Degree |
University of Illinois | Doctorate Degree |
Statistiche
Distribuzione geografica
Stati Uniti | 7 |
Posizioni
Director/Board Member | 1 |
Chief Tech/Sci/R&D Officer | 1 |
Corporate Officer/Principal | 1 |
Settori
Health Technology | 4 |
Consumer Services | 3 |
Energy Minerals | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Aziende private | 4 |
---|---|
TheraVasc, Inc.
![]() TheraVasc, Inc. Pharmaceuticals: MajorHealth Technology TheraVasc, Inc. operates as a pharmaceutical company. It develops treatments for various chronic medical diseases and drugs for unserved vascular disease markets. The company was founded by Anthony Giordano, Christopher Kevil and James Douglas Boudreaux in 2008 and is headquartered in Cleveland, OH. | Health Technology |
BioTheryX, Inc.
![]() BioTheryX, Inc. Pharmaceuticals: MajorHealth Technology BioTheryX, Inc. pengages in the development of clinical drugs. It focuses on the restoration of protein homeostasis, including protein degradation and modulation, and multi-kinase inhibition. The company was founded by David I. Stirling and Lawrence Zaslow in 2007 and is headquartered in Chappaqua, NY. | Health Technology |
Celgene Corp.
![]() Celgene Corp. BiotechnologyHealth Technology Celgene Corp. is an integrated global biopharmaceutical company, which engages in the discovery, development and commercialization of therapies for the treatment of cancer and inflammatory diseases. Its primary commercial stage products include Revlimid, Pomalyst, Imnovid, Otezla, Abraxane, and Vidaza. The company was founded by David Stirling and Sol Barer in 1986 and is headquartered in Summit, NJ. | Health Technology |
NovaDx Ventures Corp.
![]() NovaDx Ventures Corp. CoalEnergy Minerals NovaDx Ventures Corp. is a mining investment company. It engages in the exploration, development, and recovery of coal reserves. The company was founded on September 19, 1983 and is headquartered in Knoxville, TN. | Energy Minerals |
- Borsa valori
- Insiders
- Kyle W. H. Chan
- Esperienza